| Mon, Nov 16, 2009 | | | Updates and Results From Aastrom's Vascular Program Presented at an American Heart Association Satellite Symposium GlobeNewswire (Mon, Nov 16)
| | | Interim Results From Aastrom's IMPACT-DCM Cardiac Trial Presented at The American Heart Association Meeting GlobeNewswire (Mon, Nov 16)
| | Fri, Nov 13, 2009 | | | AASTROM BIOSCIENCES INC Financials EDGAR Online Financials (Fri, Nov 13)
| | | Trading Outlook for Hard To Treat Diseases Inc. Issued by InvestorSoup.com GlobeNewswire (Fri, Nov 13)
| | Wed, Nov 11, 2009 | | | Can Stem Cells Put an End To Paralysis? Indie Research (Wed, Nov 11)
| | Tue, Nov 10, 2009 | | | Aastrom to Initiate Second Phase II Clinical Trial for Treatment of Severe Chronic Heart Failure GlobeNewswire (Tue, Nov 10)
| | Mon, Nov 9, 2009 | | | Morningstar Strategist Says Healthcare Bill Will Be Law By End Of Year: Is Your Portfolio Ready? Wall Street Transcript (Mon, Nov 9)
| | Fri, Nov 6, 2009 | | | AASTROM BIOSCIENCES INC Files SEC form 8-K, Results of Operations and Financial Condition EDGAR Online (Fri, Nov 6)
| | | Aastrom Biosciences Reports First Quarter Fiscal Year 2010 Financial Results GlobeNewswire (Fri, Nov 6)
| | Fri, Oct 30, 2009 | | | Stem Cell Traders Flock to Geron Indie Research (Fri, Oct 30)
| | | Integrity Media: Stem Cell Report Released GlobeNewswire (Fri, Oct 30)
| | Tue, Oct 27, 2009 | | | AASTROM BIOSCIENCES INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhib EDGAR Online (Tue, Oct 27)
| | Tue, Oct 20, 2009 | | | AASTROM BIOSCIENCES INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhib EDGAR Online (Tue, Oct 20)
| | | Harold C. Urschel, Jr., M.D. Joins Aastrom Biosciences' Board of Directors GlobeNewswire (Tue, Oct 20)
| | Fri, Oct 9, 2009 | | | Another Coin-Flip Bet on a Stem Cell Drug Indie Research (Fri, Oct 9)
| | Wed, Oct 7, 2009 | | | Aastrom Biosciences receives delisting notice AP (Wed, Oct 7)
| | | AASTROM BIOSCIENCES INC Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Sta EDGAR Online (Wed, Oct 7)
| | | Aastrom Receives Letter From NASDAQ Regarding Continued Non-Compliance With Minimum Bid Price Rule GlobeNewswire (Wed, Oct 7)
| | Wed, Sep 30, 2009 | | | Stem Cell Summit Can't Excite Investors Indie Research (Wed, Sep 30)
| | Thu, Sep 24, 2009 | | | Aastrom Biosciences to Present At Maxim Group Growth Conference GlobeNewswire (Thu, Sep 24)
| Add ASTM News to My Yahoo!:

| |
|